Bio-Techne Corp (TECH) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Bio-Techne Corp (TECH) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How TECH Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $1.22B | 64.8% | 8.4% | $73.4M | $256.6M | 3.3% |
| FY 2024 | $1.16B | 66.4% | 17.8% | $168.1M | $236.1M | 6.5% |
| FY 2023 | $1.14B | 44% | 26.3% | $285.3M | $203.2M | 6.2% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring TECH)
- ✓Live walkthrough of TECH's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
TECH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +5.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on TECH today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for TECH. Explore sector supply chains on /butterfly.
TECH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Bio-Techne Corp (TECH)?
In FY 2025 (10-K), TECH converted $1.2B of revenue into a 64.8% gross margin, 8.4% operating margin, and $256.6M in free cash flow (21% FCF margin).